The CE mark also allows Medtronic’s automated insulin delivery system to be used during pregnancy and by children as young as 2.

Inspired by a hitchhiking fish that uses a specialized suction organ to latch onto sharks and other marine animals, researchers from MIT and other institutions have designed a mechanical adhesive device that can attach to soft surfaces underwater or in extreme conditions, and remain there for days or weeks.

TUSTIN, Calif., July 22, 2025 /PRNewswire/ — Celluma Light Therapy, the global leader in award-winning, clinically backed LED technology, announces the launch of the Celluma NOVA, the first-of-its-kind battery-powered, shape-taking LED panel with five FDA-cleared treatment modes. The Celluma NOVA treats aging skin, pain, hair restoration, body contouring, and acne — all in a single compact, rechargeable device.

New devices designed to streamline and personalize HYQVIA® administration for patients receiving subcutaneous immune globulin therapy

Patent strengthens company’s IP portfolio as it expands innovative treatments for chronic pain, oncology, and other high-need conditions

Researchers from the University of Turku and Turku University Hospital, Finland, led by Docent Sami Ventelä and Professor Jukka Westermarck, have developed a diagnostic tool that can revolutionize the treatment guidance of head and neck squamous cell carcinoma.

By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to the treatment, leading to positive outcomes for patients, according to new research by investigators at the Johns Hopkins Kimmel Cancer Center Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Netherlands Cancer Institute.

For patients with Parkinson’s disease, changes in their ability to walk can be dramatic. “Parkinson’s gait,” as it is often called, can include changes in step length and asymmetry between legs. This gait dysfunction reduces a person’s mobility, increases fall risk, and significantly impacts a patient’s quality of life.

An antibody treatment developed at Stanford Medicine successfully prepared patients for stem cell transplants without toxic busulfan chemotherapy or radiation, a Phase I clinical trial has shown.

The Global Neurodegeneration Proteomics Consortium (GNPC) has published a series of research papers detailing their efforts to identify patterns in neurodegenerative disease.